Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The Champions League league phase is coming to an end. In a breath-stopping final matchday, with all 18 games kicking off simultaneously, almost everything is still up for grabs. The only certainties ...
The final round of league phase fixtures in the 2025-26 Champions League is finally upon us, and it promises to be the most dramatic yet. Only table toppers Arsenal and Bayern Munich have already ...